Jundishapur Journal of Chronic Disease Care

Published by: Kowsar

Association Between Depot-Medroxyprogesterone Acetate Injection and Periodontal Health in Reproductive Age Women: A Case Control Study in Iran

Firozeh Bagheri 1 , Mitra Tadayon 1 , * , Poorandokht Afshari 1 , Mahmoud Jahangirneghad 2 and Mohammad Hosein Haghighizadeh 3
Authors Information
1 Department of Midwifery, Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Periodontology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Epidemiology and Statistic, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Chronic Disease Care: July 01, 2016, 5 (3); e36922
  • Published Online: April 25, 2016
  • Article Type: Research Article
  • Received: February 5, 2016
  • Revised: March 7, 2016
  • Accepted: April 8, 2016
  • DOI: 10.17795/jjcdc-36922

To Cite: Bagheri F, Tadayon M, Afshari P, Jahangirneghad M, Haghighizadeh M H. Association Between Depot-Medroxyprogesterone Acetate Injection and Periodontal Health in Reproductive Age Women: A Case Control Study in Iran, Jundishapur J Chronic Dis Care. 2016 ; 5(3):e36922. doi: 10.17795/jjcdc-36922.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Nouhjah S, Amiri E, Khodai A, Yazdanpanah A, Nadi Baghu M. Popular contraceptive methods in women aged 35 years and older attending health centers of 4 cities in khuzestan province, iran. Iran Red Crescent Med J. 2013; 15(10)[DOI][PubMed]
  • 2. Brind J, Condly SJ, Mosher SW, Morse AR, Kimball J. Risk of HIV Infection in Depot-Medroxyprogesterone Acetate (DMPA) Users: A Systematic Review and Meta-analysis. Issues Law Med. 2015; 30(2): 129-39[PubMed]
  • 3. Curry L, Taylor L, Pallas SW, Cherlin E, Perez-Escamilla R, Bradley EH. Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model. Reprod Health. 2013; 10: 39[DOI][PubMed]
  • 4. Lopez LM, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst FM. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2013; 7[DOI][PubMed]
  • 5. Fathizadeh N, Abdi F, Savabi M. A comparative study on satisfaction from hormonal contraceptives: depot medroxyprogesterone acetate (DMPA), Cyclofem and LD. Iran J Nurs Midwifery Res. 2011; 16(4): 304-8[PubMed]
  • 6. Jacobstein R, Polis CB. Progestin-only contraception: injectables and implants. Best Pract Res Clin Obstet Gynaecol. 2014; 28(6): 795-806[DOI][PubMed]
  • 7. Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005; (25): 1-160[PubMed]
  • 8. Mohebbi-Kian E, Mohammad-Alizadeh-Charandabi S, Bekhradi R. Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial. Contraception. 2014; 90(4): 440-6[DOI][PubMed]
  • 9. Chaudhri R, Rizvi F, Afzal M. Body weight and bleeding pattern changes in women using DMPA-SC. J Coll Physicians Surg Pak. 2009; 19(10): 618-21[DOI][PubMed]
  • 10. Ozgoli G, Sheikhan Z, Dolatian M, Simbar M, Bakhtyari M, Nasiri M. Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem. J Reprod Infertil. 2015; 16(2): 102-8[PubMed]
  • 11. Modesto W, Bahamondes MV, Bahamondes L. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate. J Womens Health (Larchmt). 2015; 24(8): 636-40[DOI][PubMed]
  • 12. Seck-Diallo A, Cisse ML, Benoist HM, Diouf A, Ahnoux-Kouadio A, Diallo T, et al. [Periodontal status in a sample of Senegalese women using hormonal contraception]. Odontostomatol Trop. 2008; 31(121): 36-42[PubMed]
  • 13. Taichman LS, Sohn W, Kolenic G, Sowers M. Depot medroxyprogesterone acetate use and periodontal health in 15- to 44-year-old US females. J Periodontol. 2012; 83(8): 1008-17[DOI][PubMed]
  • 14. Kazerooni T, Ghaffarpasand F, Rastegar N, Kazerooni Y. Effect of levonorgestrel implants on the periodontium. Int J Gynaecol Obstet. 2008; 103(3): 255-6[DOI][PubMed]
  • 15. Tilakaratne A, Soory M, Ranasinghe AW, Corea SM, Ekanayake SL, de Silva M. Effects of hormonal contraceptives on the periodontium, in a population of rural Sri-Lankan women. J Clin Periodontol. 2000; 27(10): 753-7[PubMed]
  • 16. Domingues RS, Ferraz BF, Greghi SL, Rezende ML, Passanezi E, Sant'Ana AC. Influence of combined oral contraceptives on the periodontal condition. J Appl Oral Sci. 2012; 20(2): 253-9[PubMed]
  • 17. Soory M, Tilakaratne A. Modulation of androgen metabolism by phenytoin, oestradiol and tamoxifen in human gingival fibroblasts. J Clin Periodontol. 2003; 30(6): 556-61[PubMed]
  • 18. Tilakaratne A, Soory M. Effects of the anti-androgen finasteride on 5 alpha-reduction of androgens in the presence of progesterone in human gingival fibroblasts: modulatory actions of the alkaline phosphatase inhibitor levamisole. J Periodontal Res. 2000; 35(4): 179-85[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments